No way [Dissolution / BCS / IVIVC]

posted by yuvaneshwari – India, 2019-01-28 06:16 (2000 d 07:17 ago) – Posting: # 19815
Views: 2,805

Thanks for your response. I was hoping to justify the waiver on the basis of sameness of finished test product against reference. I understand that criticality still remain since the molecule is BCS II drug. Thank you.


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Ohlbe]

Complete thread:

UA Flag
Activity
 Admin contact
23,112 posts in 4,858 threads, 1,644 registered users;
87 visitors (0 registered, 87 guests [including 15 identified bots]).
Forum time: 14:34 CEST (Europe/Vienna)

Statistics means you never have to say you’re certain.    David L. Streiner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5